Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Pharmacol Sci. 2004 Jun;25(6):291-4.

ACE2: from vasopeptidase to SARS virus receptor.

Author information

1
School of Biochemistry and Microbiology, University of Leeds, Leeds LS2 9JT, UK. a.j.turner@leeds.ac.uk

Abstract

The zinc metallopeptidase angiotensin-converting enzyme 2 (ACE2) is the only known human homologue of the key regulator of blood pressure angiotensin-converting enzyme (ACE). Since its discovery in 2000, ACE2 has been implicated in heart function, hypertension and diabetes, with its effects being mediated, in part, through its ability to convert angiotensin II to angiotensin-(1-7). Unexpectedly, ACE2 also serves as the cellular entry point for the severe acute respiratory syndrome (SARS) virus and the enzyme is therefore a prime target for pharmacological intervention on several disease fronts.

PMID:
15165741
DOI:
10.1016/j.tips.2004.04.001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center